Dronspot Spot On For Medium Cats

Presentation

Dronspot spot-on solution for cats is a clear yellow to brown solution. The product is presented in a single use plastic tube for dermal (spot-on) application.

Dronspot spot-on solution for medium cats is a 0.70 ml tube containing 60 mg praziquantel and 15 mg emodepside with 3.78 mg Butylhydroxyanisole (E320) as excipient.

Uses

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

Roundworms (Nematodes)

- Toxocara cati (mature adult, immature adult, larval stages L4 and L3)

- Toxocara cati (larval stage L3) – treatment of queens during late pregnancy to prevent lactogenic transmission to the offspring

- Toxascaris leonina (mature adult, immature adult and larval stage L4)

- Ancylostoma tubaeforme (mature adult, immature adult and larval stage L4)

Tapeworms (Cestodes)

- Dipylidium caninum (mature adult and immature adult)

- Taenia taeniaeformis (adult)

- Echinococcus multilocularis (adult)

Dosage and Administration

The recommended minimum doses are 3 mg emodepside/kg body weight and 12 mg praziquantel/kg body weight, equivalent to 0.14 ml Dronspot/kg body weight.

Use one pipette of Dronspot Spot On For Medium Cats for cats between 2.5kg - 5kg.

Use During Pregnancy and Lactation

Dronspot can be used during pregnancy and lactation.

Contra - Indications & Warnings

Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.

Do not use in known cases of hypersensitivity to the active substances or to any of the excipients.

Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. Treated animals therefore should not be bathed until the solution has dried.

Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

Apply only to the skin surface and on intact skin. Do not administer orally or parenterally.

Avoid the treated cat or other cats in the household licking the site of application while it is wet.

There is limited experience on the use of the product in sick and debilitated animals. Therefore the product should not be administered to these animals.

Salivation (drooling) and vomiting may occur in very rare cases. Mild and transient neurological disorders such as ataxia (unsteady or stumbling gait) or tremor may occur in very rare cases. These effects are thought to occur as a result of the cat licking the application site immediately after treatment. In very rare cases following administration of the product transient alopecia (hair loss), pruritus (itchiness) and/or inflammation were observed at the application site.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals treated displaying adverse reaction(s))

- common (more than 1 but less than 10 animals in 100 animals treated)

- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

- rare (more than 1 but less than 10 animals in 10,000 animals treated)

- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Salivation, vomiting and neurological signs (tremor) were observed occasionally when the product was administered at up to 10 times the recommended dose in adult cats and up to 5 times the recommended dose in kittens. These symptoms were thought to occur as a result of the cat licking the application site. The symptoms were completely reversible. There is no known specific antidote.

Emodepside is a substrate for P-glycoprotein. Co-treatment with other drugs that are P-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and cyclosporine) could give rise to pharmacokinetic drug interactions. The potential clinical consequences of such interactions have not been investigated. If your cat is receiving any medications, please contact your vet to discuss this before applying the product. Similarly, please inform your vet that you are using this product if s/he provides your cat with any medication.

The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.

Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.

User Safety

Read the package leaflet before use.

Avoid direct contact with application area while it is wet. Keep children away from treated animals during that time.

Wash hands after use.

In case of accidental spillage onto skin, wash off immediately with soap and water.

If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water.

If skin or eye symptoms persist, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Care should be taken not to allow children to have prolonged intensive contact (for example, by sleeping) with treated cats during the first 24 hours after application of the product.

Environmental Safety

The veterinary medicinal product should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

Pharmaceutical Precautions

Store in the original package in order to protect from moisture.

Store below 25°C

Legal Category

NFA-VPS 

You can see a directory of all veterinary medicines here

We acquired this data from the Noah Compendium, please see a link to this product here

If you have any queries please contact one of our Animal Medicines Advisors here